Grants

Our Grantmaking in 2019

  • Total

    $44,095,000 through June 2019

    Click on the diagram sections for information specific to each of our program areas listed below.

    View grantmaking in 2018
  • Program Area

    Other

    0

    This amount represents our total giving for non-priority grantmaking which includes small and matching discretionary grant programs for board members, staff and members of the Hilton family.

    View 2019 grants
  • Program Area

    Catholic Sisters

    $12,750,000

    This amount represents our total giving for building a global Catholic sisterhood to advance human development.

    About Program
  • Program Area

    Catholic Education

    $2,700,000

    This amount represents our total giving for revitalizing Catholic schools serving low-income families.

    About Program View 2019 grants
  • Program Area

    Avoidable Blindness

    0

    This amount represents our total giving for preventing avoidable sight loss from cataracts and blinding trachoma.

    About Program
  • Program Area

    Disaster Relief & Recovery

    0

    This amount represents our total giving for supporting disaster preparedness, relief, and long-term recovery.

    About Program
  • Program Area

    Young Children Affected by HIV and AIDS

    0

    This amount represents our total giving for the year to date for improving early childhood development outcomes for young children affected by HIV and AIDS.

    About Program View 2019 grants
  • Program Area

    Substance Use Prevention

    $8,415,000

    This amount represents our total giving for youth substance use prevention and early intervention.

    About Program
  • Program Area

    Multiple Sclerosis

    $2,200,000

    This amount represents our total giving for seeking a cure and improving quality of life for those who live with multiple sclerosis.

    About Program
  • Program Area

    Hospitality

    $3,250,000

    This amount represents our total giving for building career pathways for youth in the hospitality sector.

    About Program
  • Program Area

    Homelessness

    $550,000

    This amount represents our total giving for ending chronic homelessness in Los Angeles County.

    About Program
  • Program Area

    Foster Youth

    $4,730,000

    This amount represents our total giving for the year to date for achieving healthy and productive lives for transition age youth in foster care.

    About Program View 2019 grants
  • Program Area

    Safe Water

    $9,000,000

    This amount represents our total giving for increasing access to safe water for vulnerable and disadvantaged communities.

    About Program View 2019 grants
  • Substance Use Prevention

  • Multiple Sclerosis

  • Avoidable Blindness

  • Hospitality

  • Disaster Relief & Recovery

  • Homelessness

  • Catholic Sisters

  • Catholic Education

  • Other

  • Young Children Affected by HIV and AIDS

  • Foster Youth

  • Safe Water

This total represents grant payment activity during the selected fiscal year. However, approximately 90% of the money awarded in our program areas is part of multi-year commitments, so a grant may appear in multiple years of activity. The list below provides additional information about specific projects approved and/or paid during the fiscal year selected, including the project start date and the length of our commitment.

  1. Regents of the University of California Los Angeles

    $1,600,000 through May 2022

    To support Dr. Rhonda Voskuhl's research on disability-specific disease modifying treatments in multiple sclerosis. http://www.research.ucla.edu

    Multiple Sclerosis USA Awarded: May 2019
  2. Mercy Foundation

    $600,000 through July 2022

    To support the MS Achievement Center serving Sacramento and the Northern California region. http://www.supportmercyfoundation.org

    Multiple Sclerosis USA Awarded: May 2019
  3. American Brain Foundation

    $65,000 through May 2018

    to support the launch of a new crowdfunding platform for campaigns focused on research in Multiple Sclerosis during MS Awareness Month. https://www.americanbrainfoundation.org

    Multiple Sclerosis USA Awarded: March 2018
  4. Regents of the University of California Los Angeles

    $185,000 through October 2019

    to support planning for a phase III clinical trial of estriol. http://www.research.ucla.edu

    Multiple Sclerosis USA Awarded: November 2017
  5. J. David Gladstone Institutes

    $405,000 through October 2019

    to support research on the coagulation cascade as a biomarker for progressive multiple sclerosis. www.gladstoneinstitutes.org

    Multiple Sclerosis USA Awarded: November 2017
  6. National Institutes of Health

    $74,062 through June 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS. www.nih.gov

    Multiple Sclerosis USA Awarded: October 2017
  7. Icahn School of Medicine at Mount Sinai

    $117,584 through June 2021

    to study astrocytic regulation of immune cell activity during central nervous system inflammation. http://icahn.mssm.edu

    Multiple Sclerosis USA Awarded: May 2017
  8. Massachusetts General Hospital

    $120,000 through June 2020

    to develop imaging markers of axonal damage and myelin integrity in MS patients using ultra-high gradient MRI techniques. http://www.massgeneral.org/

    Multiple Sclerosis USA Awarded: May 2017
  9. Johns Hopkins University

    $585,000 through June 2022

    to study how to reduce chronic inflammation in MS patients. www.nih.gov

    Multiple Sclerosis USA Awarded: May 2017
  10. Regents of the University of Colorado

    $120,000 through June 2019

    to study mechanisms regulating MS-related myelin injury and repair in cortical lesions. http://www.ucdenver.edu

    Multiple Sclerosis USA Awarded: May 2017
  11. Baylor College of Medicine

    $120,000 through June 2019

    to study how targeting the Wnt receptor complex may increase myelin repair in MS patients. www.bcm.edu

    Multiple Sclerosis USA Awarded: May 2017
  12. Regents of the University of California, Irvine

    $120,000 through June 2019

    to study whether lower GlcNAc levels promote the progression of MS by preventing oligodendrocyte formation and reducing remyelination. http://www.research.uci.edu

    Multiple Sclerosis USA Awarded: May 2017
  13. New York Stem Cell Foundation, Inc.

    $120,000 through December 2019

    to study the properties of oligodendrocyte progenitor cells in MS. http://www.nyscf.org

    Multiple Sclerosis USA Awarded: May 2017
  14. Washington University

    $120,000 through June 2020

    to identify biomarkers in cerebrospinal fluid that may predict MS disease progression and responses to therapy. http://www.wustl.edu

    Multiple Sclerosis USA Awarded: May 2017
  15. Vanderbilt University Medical Center

    $120,000 through June 2020

    to apply advanced imaging to the study of the cervical spinal cord in patients with MS. https://www.mc.vanderbilt.edu

    Multiple Sclerosis USA Awarded: May 2017
  16. Johns Hopkins University

    $535,000 through June 2021

    to study signaling pathways that lead to free radical damage in MS patients. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  17. Trustees of the University of Pennsylvania

    $552,710 through September 2021

    to use advanced imaging techniques to study what role astrocytes cells in the cortex may play in promoting remyelination in MS. http://www.upenn.edu

    Multiple Sclerosis USA Awarded: May 2017
  18. University of Southern California

    $120,000 through December 2019

    to study the potential of angiotensin 1-7 to promote oligodendrocyte progenitor cell remyelination. http://www.usc.edu

    Multiple Sclerosis USA Awarded: May 2017
  19. Johns Hopkins University

    $45,938 through June 2019

    to identify new biomarkers of inflammation and neurodegeneration using the plasma of patients with MS. http://www.jhu.edu

    Multiple Sclerosis USA Awarded: May 2017
  20. University of California, San Francisco

    $120,000 through June 2019

    to study misfolded tau aggregates found in the brains of MS patients. http://www.ucsf.edu

    Multiple Sclerosis USA Awarded: May 2017